Multisite multivendor validation of a quantitative MRI and CT compatible fat phantom
Authors:
- 9 July 2021
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 48 (8) , 4375-4386
Abstract
Purpose: Chemical shift‐encoded magnetic resonance imaging enables accurate quantification of liver fat content though estimation of proton density fat‐fraction (PDFF). Computed tomography (CT) is capable of quantifying fat, based on decreased attenuation with increased fat concentration. Current quantitative fat phantoms do not accurately mimic the CT number of human liver. The purpose of this work was to develop and validate an optimized phantom that simultaneously mimics the MRI and CT signals of fatty liver.Methods: An agar‐based phantom containing 12 vials doped with iodinated contrast, and with a granular range of fat fractions was designed and constructed within a novel CT and MR compatible spherical housing design. A four‐site, three‐vendor validation study was performed. MRI (1.5T and 3T) and CT images were obtained using each vendor's PDFF and CT reconstruction, respectively. An ROI centered in each vial was placed to measure MRI‐PDFF (%) and CT number (HU). Mixed‐effects model, linear regression, and Bland‐Altman analysis were used for statistical analysis.Results: MRI‐PDFF agreed closely with nominal PDFF values across both field strengths and all MRI vendors. A linear relationship (slope = −0.54 ± 0.01%/HU, intercept = 37.15 ± 0.03%) with an R2 of 0.999 was observed between MRI‐PDFF and CT number, replicating established in vivo signal behavior. Excellent test‐retest repeatability across vendors (MRI: mean = −0.04%, 95% limits of agreement = [−0.24%, 0.16%]; CT: mean = 0.16 HU, 95% limits of agreement = [−0.15HU, 0.47HU]) and good reproducibility using GE scanners (MRI: mean = −0.21%, 95% limits of agreement = [−1.47%, 1.06%]; CT: mean = −0.18HU, 95% limits of agreement = [−1.96HU, 1.6HU]) were demonstrated.Conclusions: The proposed fat phantom successfully mimicked quantitative liver signal for both MRI and CT. The proposed fat phantom in this study may facilitate broader application and harmonization of liver fat quantification techniques using MRI and CT across institutions, vendors and imaging platforms.Keywords
Funding Information
- National Institutes of Health (R01 DK088925, R01 DK100651, R41 EB025729, R44 EB025729, K24 DK102595, R01 DK083380)
This publication has 32 references indexed in Scilit:
- Quantification of Hepatic Steatosis With Dual-Energy Computed TomographyInvestigative Radiology, 2012
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Quantification of Liver Fat with Magnetic Resonance ImagingMagnetic Resonance Imaging Clinics of North America, 2010
- Robust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithmMagnetic Resonance in Medicine, 2009
- T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: Validation in a fat‐water‐SPIO phantomJournal of Magnetic Resonance Imaging, 2009
- Multiecho water‐fat separation and simultaneous R estimation with multifrequency fat spectrum modelingMagnetic Resonance in Medicine, 2008
- Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease, 2008
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C†Hepatology, 2006
- Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures DataJournal of the American Statistical Association, 1988
- Long-term amiodarone therapy: a cause of increased hepatic attenuation on CTBritish Journal of Radiology, 1984